Light-Activated gel shows promise for psoriasis skin relief
Disease control
Completed
This study tested a new topical ointment called SGX302, which is activated by visible light, to see if it could improve skin lesions in people with mild-to-moderate plaque psoriasis. Fifteen participants applied the treatment to their skin for an 18-week course. The main goal was…
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC